The outcome of stenting and its duration after pyeloplasty in children with ureteropelvic junction obstruction (UPJO): a systematic review and meta-analysis

Background The complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of several pyeloplasty techniques. Methods A systematic search was performed using PubMed/MEDLINE, ScienceDirect, and Cochrane databases, selec...

Full description

Saved in:
Bibliographic Details
Published inBMC urology Vol. 25; no. 1; pp. 227 - 10
Main Authors Wiratma, Made Kresna Yudhistira, Ghinorawa, Tanaya, Yuri, Prahara
Format Journal Article
LanguageEnglish
Published London BioMed Central 03.09.2025
BioMed Central Ltd
BMC
Subjects
Bladder
Case reports
Child
Children
Complications
Health aspects
Humans
Hydronephrosis
Implants
Infections
Internal Medicine
Kidney Pelvis - surgery
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Meta-analysis
Patients
Pediatric Patients
Pediatrics
Postoperative Complications - epidemiology
Pyeloplasty
Stent
Stent (Surgery)
Stents
Stents - adverse effects
Surgery
Surgical outcomes
Systematic review
Time Factors
Treatment Outcome
Ureteral Obstruction - surgery
Ureteropelvic Junction Obstruction
Urinary incontinence
Urine
Urogenital system
Urologic Surgical Procedures - methods
Urology
Pediatric Patients
Ureteropelvic Junction Obstruction
Complications
Stent
Pyeloplasty
Online AccessGet full text
ISSN1471-2490
1471-2490
DOI10.1186/s12894-025-01841-4

Cover

Abstract Background The complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of several pyeloplasty techniques. Methods A systematic search was performed using PubMed/MEDLINE, ScienceDirect, and Cochrane databases, selecting cohort and controlled trial studies until April 2023. The following medical subject headings (MeSH) were included in the search: stent, ureteropelvic junction obstruction, pyeloplasty and children. Complication and success rate related to the stent placement after pyeloplasty were recorded. Results Eleven studies including 1072 patients were included. Eight studies compared stented versus non-stented pyeloplasty. Three studies compared 4-week stenting vs ≤ 2-week stenting. The total complication risk is decreased in stented group compared to non-stented group (OR 0.81, 95% CI 0.59–1.13). According to subgroup analysis, urinary leakage (OR 0.21 95% CI 0.10–0.47) and obstruction (OR 0.69 95% CI 0.32–1.47) are decreased in stented group. The total risk of complication is increased in 4-week stenting period (OR 5.11, 95% CI 2.43- 10.74) compared to ≤ 2-week stenting period, with the OR of each subgroup analysis is 4.64, 95% CI 1.8–11.97; 4.36, 95% CI 0.5–38.3 and 6.78, 95% CI 1.65–27.92 for fever, stent migration, and irritative symptom, respectively. There were no differences of success rate among the groups (OR 0.48, 95% CI 0.04–5.62). Conclusion The use of stent can reduce the risk of urinary leakage after pyeloplasty in children. Stenting duration ≤ 2 weeks carries a smaller risk of complications with the same post operative success rate as stents with a longer duration.
AbstractList The complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of several pyeloplasty techniques. A systematic search was performed using PubMed/MEDLINE, ScienceDirect, and Cochrane databases, selecting cohort and controlled trial studies until April 2023. The following medical subject headings (MeSH) were included in the search: stent, ureteropelvic junction obstruction, pyeloplasty and children. Complication and success rate related to the stent placement after pyeloplasty were recorded. Eleven studies including 1072 patients were included. Eight studies compared stented versus non-stented pyeloplasty. Three studies compared 4-week stenting vs [less than or equal to] 2-week stenting. The total complication risk is decreased in stented group compared to non-stented group (OR 0.81, 95% CI 0.59-1.13). According to subgroup analysis, urinary leakage (OR 0.21 95% CI 0.10-0.47) and obstruction (OR 0.69 95% CI 0.32-1.47) are decreased in stented group. The total risk of complication is increased in 4-week stenting period (OR 5.11, 95% CI 2.43- 10.74) compared to [less than or equal to] 2-week stenting period, with the OR of each subgroup analysis is 4.64, 95% CI 1.8-11.97; 4.36, 95% CI 0.5-38.3 and 6.78, 95% CI 1.65-27.92 for fever, stent migration, and irritative symptom, respectively. There were no differences of success rate among the groups (OR 0.48, 95% CI 0.04-5.62). The use of stent can reduce the risk of urinary leakage after pyeloplasty in children. Stenting duration [less than or equal to] 2 weeks carries a smaller risk of complications with the same post operative success rate as stents with a longer duration.
Background The complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of several pyeloplasty techniques. Methods A systematic search was performed using PubMed/MEDLINE, ScienceDirect, and Cochrane databases, selecting cohort and controlled trial studies until April 2023. The following medical subject headings (MeSH) were included in the search: stent, ureteropelvic junction obstruction, pyeloplasty and children. Complication and success rate related to the stent placement after pyeloplasty were recorded. Results Eleven studies including 1072 patients were included. Eight studies compared stented versus non-stented pyeloplasty. Three studies compared 4-week stenting vs [less than or equal to] 2-week stenting. The total complication risk is decreased in stented group compared to non-stented group (OR 0.81, 95% CI 0.59-1.13). According to subgroup analysis, urinary leakage (OR 0.21 95% CI 0.10-0.47) and obstruction (OR 0.69 95% CI 0.32-1.47) are decreased in stented group. The total risk of complication is increased in 4-week stenting period (OR 5.11, 95% CI 2.43- 10.74) compared to [less than or equal to] 2-week stenting period, with the OR of each subgroup analysis is 4.64, 95% CI 1.8-11.97; 4.36, 95% CI 0.5-38.3 and 6.78, 95% CI 1.65-27.92 for fever, stent migration, and irritative symptom, respectively. There were no differences of success rate among the groups (OR 0.48, 95% CI 0.04-5.62). Conclusion The use of stent can reduce the risk of urinary leakage after pyeloplasty in children. Stenting duration [less than or equal to] 2 weeks carries a smaller risk of complications with the same post operative success rate as stents with a longer duration. Keywords: Stent, Ureteropelvic Junction Obstruction, Pyeloplasty, Complications, Pediatric Patients
The complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of several pyeloplasty techniques. A systematic search was performed using PubMed/MEDLINE, ScienceDirect, and Cochrane databases, selecting cohort and controlled trial studies until April 2023. The following medical subject headings (MeSH) were included in the search: stent, ureteropelvic junction obstruction, pyeloplasty and children. Complication and success rate related to the stent placement after pyeloplasty were recorded. Eleven studies including 1072 patients were included. Eight studies compared stented versus non-stented pyeloplasty. Three studies compared 4-week stenting vs ≤ 2-week stenting. The total complication risk is decreased in stented group compared to non-stented group (OR 0.81, 95% CI 0.59-1.13). According to subgroup analysis, urinary leakage (OR 0.21 95% CI 0.10-0.47) and obstruction (OR 0.69 95% CI 0.32-1.47) are decreased in stented group. The total risk of complication is increased in 4-week stenting period (OR 5.11, 95% CI 2.43- 10.74) compared to ≤ 2-week stenting period, with the OR of each subgroup analysis is 4.64, 95% CI 1.8-11.97; 4.36, 95% CI 0.5-38.3 and 6.78, 95% CI 1.65-27.92 for fever, stent migration, and irritative symptom, respectively. There were no differences of success rate among the groups (OR 0.48, 95% CI 0.04-5.62). The use of stent can reduce the risk of urinary leakage after pyeloplasty in children. Stenting duration ≤ 2 weeks carries a smaller risk of complications with the same post operative success rate as stents with a longer duration.
Abstract Background The complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of several pyeloplasty techniques. Methods A systematic search was performed using PubMed/MEDLINE, ScienceDirect, and Cochrane databases, selecting cohort and controlled trial studies until April 2023. The following medical subject headings (MeSH) were included in the search: stent, ureteropelvic junction obstruction, pyeloplasty and children. Complication and success rate related to the stent placement after pyeloplasty were recorded. Results Eleven studies including 1072 patients were included. Eight studies compared stented versus non-stented pyeloplasty. Three studies compared 4-week stenting vs ≤ 2-week stenting. The total complication risk is decreased in stented group compared to non-stented group (OR 0.81, 95% CI 0.59–1.13). According to subgroup analysis, urinary leakage (OR 0.21 95% CI 0.10–0.47) and obstruction (OR 0.69 95% CI 0.32–1.47) are decreased in stented group. The total risk of complication is increased in 4-week stenting period (OR 5.11, 95% CI 2.43- 10.74) compared to ≤ 2-week stenting period, with the OR of each subgroup analysis is 4.64, 95% CI 1.8–11.97; 4.36, 95% CI 0.5–38.3 and 6.78, 95% CI 1.65–27.92 for fever, stent migration, and irritative symptom, respectively. There were no differences of success rate among the groups (OR 0.48, 95% CI 0.04–5.62). Conclusion The use of stent can reduce the risk of urinary leakage after pyeloplasty in children. Stenting duration ≤ 2 weeks carries a smaller risk of complications with the same post operative success rate as stents with a longer duration.
Background The complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of several pyeloplasty techniques. Methods A systematic search was performed using PubMed/MEDLINE, ScienceDirect, and Cochrane databases, selecting cohort and controlled trial studies until April 2023. The following medical subject headings (MeSH) were included in the search: stent, ureteropelvic junction obstruction, pyeloplasty and children. Complication and success rate related to the stent placement after pyeloplasty were recorded. Results Eleven studies including 1072 patients were included. Eight studies compared stented versus non-stented pyeloplasty. Three studies compared 4-week stenting vs ≤ 2-week stenting. The total complication risk is decreased in stented group compared to non-stented group (OR 0.81, 95% CI 0.59–1.13). According to subgroup analysis, urinary leakage (OR 0.21 95% CI 0.10–0.47) and obstruction (OR 0.69 95% CI 0.32–1.47) are decreased in stented group. The total risk of complication is increased in 4-week stenting period (OR 5.11, 95% CI 2.43- 10.74) compared to ≤ 2-week stenting period, with the OR of each subgroup analysis is 4.64, 95% CI 1.8–11.97; 4.36, 95% CI 0.5–38.3 and 6.78, 95% CI 1.65–27.92 for fever, stent migration, and irritative symptom, respectively. There were no differences of success rate among the groups (OR 0.48, 95% CI 0.04–5.62). Conclusion The use of stent can reduce the risk of urinary leakage after pyeloplasty in children. Stenting duration ≤ 2 weeks carries a smaller risk of complications with the same post operative success rate as stents with a longer duration.
The complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of several pyeloplasty techniques.BACKGROUNDThe complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of several pyeloplasty techniques.A systematic search was performed using PubMed/MEDLINE, ScienceDirect, and Cochrane databases, selecting cohort and controlled trial studies until April 2023. The following medical subject headings (MeSH) were included in the search: stent, ureteropelvic junction obstruction, pyeloplasty and children. Complication and success rate related to the stent placement after pyeloplasty were recorded.METHODSA systematic search was performed using PubMed/MEDLINE, ScienceDirect, and Cochrane databases, selecting cohort and controlled trial studies until April 2023. The following medical subject headings (MeSH) were included in the search: stent, ureteropelvic junction obstruction, pyeloplasty and children. Complication and success rate related to the stent placement after pyeloplasty were recorded.Eleven studies including 1072 patients were included. Eight studies compared stented versus non-stented pyeloplasty. Three studies compared 4-week stenting vs ≤ 2-week stenting. The total complication risk is decreased in stented group compared to non-stented group (OR 0.81, 95% CI 0.59-1.13). According to subgroup analysis, urinary leakage (OR 0.21 95% CI 0.10-0.47) and obstruction (OR 0.69 95% CI 0.32-1.47) are decreased in stented group. The total risk of complication is increased in 4-week stenting period (OR 5.11, 95% CI 2.43- 10.74) compared to ≤ 2-week stenting period, with the OR of each subgroup analysis is 4.64, 95% CI 1.8-11.97; 4.36, 95% CI 0.5-38.3 and 6.78, 95% CI 1.65-27.92 for fever, stent migration, and irritative symptom, respectively. There were no differences of success rate among the groups (OR 0.48, 95% CI 0.04-5.62).RESULTSEleven studies including 1072 patients were included. Eight studies compared stented versus non-stented pyeloplasty. Three studies compared 4-week stenting vs ≤ 2-week stenting. The total complication risk is decreased in stented group compared to non-stented group (OR 0.81, 95% CI 0.59-1.13). According to subgroup analysis, urinary leakage (OR 0.21 95% CI 0.10-0.47) and obstruction (OR 0.69 95% CI 0.32-1.47) are decreased in stented group. The total risk of complication is increased in 4-week stenting period (OR 5.11, 95% CI 2.43- 10.74) compared to ≤ 2-week stenting period, with the OR of each subgroup analysis is 4.64, 95% CI 1.8-11.97; 4.36, 95% CI 0.5-38.3 and 6.78, 95% CI 1.65-27.92 for fever, stent migration, and irritative symptom, respectively. There were no differences of success rate among the groups (OR 0.48, 95% CI 0.04-5.62).The use of stent can reduce the risk of urinary leakage after pyeloplasty in children. Stenting duration ≤ 2 weeks carries a smaller risk of complications with the same post operative success rate as stents with a longer duration.CONCLUSIONThe use of stent can reduce the risk of urinary leakage after pyeloplasty in children. Stenting duration ≤ 2 weeks carries a smaller risk of complications with the same post operative success rate as stents with a longer duration.
BackgroundThe complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of several pyeloplasty techniques.MethodsA systematic search was performed using PubMed/MEDLINE, ScienceDirect, and Cochrane databases, selecting cohort and controlled trial studies until April 2023. The following medical subject headings (MeSH) were included in the search: stent, ureteropelvic junction obstruction, pyeloplasty and children. Complication and success rate related to the stent placement after pyeloplasty were recorded.ResultsEleven studies including 1072 patients were included. Eight studies compared stented versus non-stented pyeloplasty. Three studies compared 4-week stenting vs ≤ 2-week stenting. The total complication risk is decreased in stented group compared to non-stented group (OR 0.81, 95% CI 0.59–1.13). According to subgroup analysis, urinary leakage (OR 0.21 95% CI 0.10–0.47) and obstruction (OR 0.69 95% CI 0.32–1.47) are decreased in stented group. The total risk of complication is increased in 4-week stenting period (OR 5.11, 95% CI 2.43- 10.74) compared to ≤ 2-week stenting period, with the OR of each subgroup analysis is 4.64, 95% CI 1.8–11.97; 4.36, 95% CI 0.5–38.3 and 6.78, 95% CI 1.65–27.92 for fever, stent migration, and irritative symptom, respectively. There were no differences of success rate among the groups (OR 0.48, 95% CI 0.04–5.62).ConclusionThe use of stent can reduce the risk of urinary leakage after pyeloplasty in children. Stenting duration ≤ 2 weeks carries a smaller risk of complications with the same post operative success rate as stents with a longer duration.
ArticleNumber 227
Audience Academic
Author Yuri, Prahara
Ghinorawa, Tanaya
Wiratma, Made Kresna Yudhistira
Author_xml – sequence: 1
  givenname: Made Kresna Yudhistira
  surname: Wiratma
  fullname: Wiratma, Made Kresna Yudhistira
  organization: Division of Urology, Department of Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr, Sardjito Hospital
– sequence: 2
  givenname: Tanaya
  surname: Ghinorawa
  fullname: Ghinorawa, Tanaya
  organization: Division of Urology, Department of Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr, Sardjito Hospital
– sequence: 3
  givenname: Prahara
  surname: Yuri
  fullname: Yuri, Prahara
  email: prahara.yuri@ugm.ac.id
  organization: Division of Urology, Department of Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr, Sardjito Hospital, Clinical Epidemiology and Biostatistic Unit (CEBU), Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr, Sardjito Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40903760$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1v1DAQhiNURNuFP8ABWeJSDin-ipNwqyqgRZXKoT1bjjPe9SqxF9tptf-FH4t30w9ACNnSjEbPvDMjvcfFgfMOiuItwaeENOJjJLRpeYlpVWLScFLyF8UR4TUpKW_xwW_5YXEc4xpjUjeVeFUcctxiVgt8VPy8WQHyU9J-zNGgmMAl65ZIuR7ZFFE_BZWsd0iZBAFttjD4zaBi2iLrkF7ZoQ_g0L1NKzQFyIzfwHBnNVpPTu87fRdTmOb85Pb7t-sPn5BCcZtnjVlbowB3Fu73I0dIqlRODdto4-vipVFDhDcPcVHcfvl8c35RXl1_vTw_uyp1hatUMoobqBvCu04JwjrRGWgaYkzLRasMBgbMEGCYE1zjmmulmWCNbistCKaELYrLWbf3ai03wY4qbKVXVu4LPiylCnnRAWTPedvhTjHDgZOqbntS1wJURbHRphdZ62TW2gT_Y4KY5GijhmFQDvwUJaNciFpULc3o-7_QtZ9Cvn1P1YS2lPBnaqnyfOuMT0Hpnag8aypOWcPyXxSn_6Dy62G0OvvG2Fz_o-Hdw_CpG6F_uvrRGhmgM6CDjzGAeUIIljv_ydl_MvtP7v0nd8uyuSlm2C0hPJ_0n65ffiDchA
Cites_doi 10.1016/j.ajur.2019.10.011
10.1007/s11934-018-0779-y
10.1016/j.jpurol.2019.10.016
10.1016/j.jpurol.2008.01.205
10.1007/s00383-020-04734-9
10.1007/s003830100660
10.1016/j.jpurol.2014.04.017
10.1016/j.juro.2011.03.103
10.1016/j.urology.2016.09.024
10.4103/jiaps.JIAPS_58_17
10.1016/S0022-5347(17)38821-3
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
DOA
DOI 10.1186/s12894-025-01841-4
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE


MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2490
EndPage 10
ExternalDocumentID oai_doaj_org_article_d449b0ba3f4e41579d1776ea520fcfd6
A854238338
40903760
10_1186_s12894_025_01841_4
Genre Meta-Analysis
Systematic Review
Journal Article
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7XB
8FK
AZQEC
DWQXO
K9.
M48
PKEHL
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c505t-3208e7814bba613b6bfe881ff9469af0e3e3f1e304107074cac3638c95c610213
IEDL.DBID C6C
ISSN 1471-2490
IngestDate Mon Sep 08 19:51:54 EDT 2025
Sat Sep 06 06:10:38 EDT 2025
Thu Sep 11 22:41:02 EDT 2025
Wed Sep 10 23:57:41 EDT 2025
Tue Sep 09 03:49:18 EDT 2025
Tue Sep 09 02:31:19 EDT 2025
Thu Sep 18 00:23:41 EDT 2025
Sat Sep 06 07:22:55 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Pediatric Patients
Ureteropelvic Junction Obstruction
Complications
Stent
Pyeloplasty
Language English
License 2025. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c505t-3208e7814bba613b6bfe881ff9469af0e3e3f1e304107074cac3638c95c610213
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://doi.org/10.1186/s12894-025-01841-4
PMID 40903760
PQID 3247129214
PQPubID 42551
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_d449b0ba3f4e41579d1776ea520fcfd6
proquest_miscellaneous_3246676592
proquest_journals_3247129214
gale_infotracmisc_A854238338
gale_infotracacademiconefile_A854238338
pubmed_primary_40903760
crossref_primary_10_1186_s12894_025_01841_4
springer_journals_10_1186_s12894_025_01841_4
PublicationCentury 2000
PublicationDate 2025-09-03
PublicationDateYYYYMMDD 2025-09-03
PublicationDate_xml – month: 09
  year: 2025
  text: 2025-09-03
  day: 03
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC urology
PublicationTitleAbbrev BMC Urol
PublicationTitleAlternate BMC Urol
PublicationYear 2025
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References FM Nasser (1841_CR6) 2017; 1
AP Bayne (1841_CR4) 2011; 186
1841_CR3
K Elmalik (1841_CR8) 2008; 4
1841_CR2
1841_CR5
MS Imam (1841_CR11) 2020; 36
1841_CR7
1841_CR12
1841_CR9
S Dey (1841_CR1) 2020; 7
1841_CR10
References_xml – ident: 1841_CR5
– volume: 7
  start-page: 327
  issue: 4
  year: 2020
  ident: 1841_CR1
  publication-title: Asian J Urol
  doi: 10.1016/j.ajur.2019.10.011
– ident: 1841_CR12
  doi: 10.1007/s11934-018-0779-y
– ident: 1841_CR2
  doi: 10.1016/j.jpurol.2019.10.016
– volume: 4
  start-page: 275
  issue: 4
  year: 2008
  ident: 1841_CR8
  publication-title: J Pediatr Urol
  doi: 10.1016/j.jpurol.2008.01.205
– volume: 36
  start-page: 1363
  issue: 11
  year: 2020
  ident: 1841_CR11
  publication-title: Pediatr Surg Int
  doi: 10.1007/s00383-020-04734-9
– ident: 1841_CR10
  doi: 10.1007/s003830100660
– ident: 1841_CR3
  doi: 10.1016/j.jpurol.2014.04.017
– volume: 186
  start-page: 1693
  issue: 4 SUPPL.
  year: 2011
  ident: 1841_CR4
  publication-title: J Urol
  doi: 10.1016/j.juro.2011.03.103
– volume: 1
  start-page: 38
  issue: 101
  year: 2017
  ident: 1841_CR6
  publication-title: Urology
  doi: 10.1016/j.urology.2016.09.024
– ident: 1841_CR7
  doi: 10.4103/jiaps.JIAPS_58_17
– ident: 1841_CR9
  doi: 10.1016/S0022-5347(17)38821-3
SSID ssj0017856
Score 2.371416
SecondaryResourceType review_article
Snippet Background The complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of...
The complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of several...
Background The complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of...
BackgroundThe complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success rates of...
Abstract Background The complication related to the use of stent and its duration are still considered in the treatment option of UPJO despite the high success...
SourceID doaj
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Publisher
StartPage 227
SubjectTerms Bladder
Case reports
Child
Children
Complications
Health aspects
Humans
Hydronephrosis
Implants
Infections
Internal Medicine
Kidney Pelvis - surgery
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Meta-analysis
Patients
Pediatric Patients
Pediatrics
Postoperative Complications - epidemiology
Pyeloplasty
Stent
Stent (Surgery)
Stents
Stents - adverse effects
Surgery
Surgical outcomes
Systematic review
Time Factors
Treatment Outcome
Ureteral Obstruction - surgery
Ureteropelvic Junction Obstruction
Urinary incontinence
Urine
Urogenital system
Urologic Surgical Procedures - methods
Urology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLojwDBRkJCRBETeJHbG4FUVWVChxYqTfLT6kVJKtu9tD_0h_LjJNsuyDEhdNKGyfr9TfjmYlnviHklWu9jo2uSytdKLmPslRC1aXgVjt0aL3HauSTL_JowY9PxemNVl-YEzbSA48Ltx84165yliUewdi0OtRtK6MVTZV8CplsG8zYHExN5wetEnIukVFyfwW7MFLgNpiopjhETVtmKLP1_7kn3zBKv52SZuNzeI_cnbxGejDOdpfcit19cvtkOhd_QK4AbdqvBxAf-EwUoMsdIKjtAj0bVjSsR6Rp7glOl5eYKQSO83BJzzo6V3RTfCtL1xeYItMv4w_YReg5GL58Z-82XLP0zeLb8de3H6il10zQdKyCyT_5Mw62tBPfyUOyOPz8_dNROfVdKD34Q0PJYEEjUmE5Z8HaO-lSVKpOSUMsbVMVWWSpjqziNZIFcW89AzX2WniJncLZI7LT9V18QqhzrfRKCu104m1yygpWhQBBWmjgOXVB3s0wmOVIr2FyWKKkGUEzAJrJoBlekI-I1GYkUmPnL0BgzCQw5l8CU5DXiLNBBR4uLEx-rEOACSMVljlQAlxMBaF7Qfa2RoLi-e3Ls6SYSfFXBvzTFlyopobJvtxcxjsxma2L_TqPwcxioZuCPB4lbPOXOL43a2VVkPezyF0__O8r8_R_rMwzcqfJKqLLiu2RHRCq-BxcrsG9yNr1C15VJ4E
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgkRCXFW8CCzISEiCwNg_HsbmgBbFarbTAgUq9WX6iRWxS2vSw_4Ufy4yTtBQEp0qNkzr9Zjwz9sw3hDyzjVOhVAUzwnrGXRBM1rJgNTfKokPrHFYjn30UJzN-Oq_n44bbakyrnNbEtFD7zuEe-SEY_gZsU1nwt4sfDLtG4enq2ELjKrlWgKuCUt3MNwEXNp4XU6GMFIcrWIuRCLfEdDXJIXbaMUaJs__vlfk30_THWWkyQcc3yf7oO9KjAexb5Epob5PrZ-Pp-B3yEzCn3bqHF4LPSAHA1AeCmtbT835F_XrAm6bO4HRxiflC4D73l_S8pVNdN8W9WbpeYqJMtwjfYS2h38D8pTs7u2GcpS9mn08_vXxDDd3yQdOhFib95EXoDTMj68ldMjv-8OX9CRu7LzAHXlHPqjKXAQmxrDVg862wMUhZxKggojYxD1WoYhGqnBdIGcSdcRUos1O1E9gvvLpH9tquDQ8ItbYRTopaWRV5E600dZV7D6GaL-E5RUZeTTDoxUCyoVNwIoUeQNMAmk6gaZ6Rd4jUZiQSZKcvuuVXPeqb9pwrm1tTRR7AR2mUL5pGBFOXeXTRi4w8R5w1qnG_NDD5oRoBJoyEWPpI1uBoSgjgM3KwMxLUz-1eniRFj-q_0lthzcjTzWW8E1Pa2tCt0xjML65VmZH7g4RtXonj7lkj8oy8nkRu-_B__zMP_z-XR-RGmYRfsbw6IHsgLuExuFS9fZL05heJhh52
  priority: 102
  providerName: ProQuest
Title The outcome of stenting and its duration after pyeloplasty in children with ureteropelvic junction obstruction (UPJO): a systematic review and meta-analysis
URI https://link.springer.com/article/10.1186/s12894-025-01841-4
https://www.ncbi.nlm.nih.gov/pubmed/40903760
https://www.proquest.com/docview/3247129214
https://www.proquest.com/docview/3246676592
https://doaj.org/article/d449b0ba3f4e41579d1776ea520fcfd6
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMedCentral
  customDbUrl:
  eissn: 1471-2490
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017856
  issn: 1471-2490
  databaseCode: RBZ
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1471-2490
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017856
  issn: 1471-2490
  databaseCode: KQ8
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1471-2490
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017856
  issn: 1471-2490
  databaseCode: KQ8
  dateStart: 20010801
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1471-2490
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017856
  issn: 1471-2490
  databaseCode: DOA
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1471-2490
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017856
  issn: 1471-2490
  databaseCode: DIK
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1471-2490
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017856
  issn: 1471-2490
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1471-2490
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017856
  issn: 1471-2490
  databaseCode: M~E
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1471-2490
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017856
  issn: 1471-2490
  databaseCode: RPM
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1471-2490
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017856
  issn: 1471-2490
  databaseCode: 7X7
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1471-2490
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017856
  issn: 1471-2490
  databaseCode: BENPR
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: Springer Nature HAS Fully OA
  customDbUrl:
  eissn: 1471-2490
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017856
  issn: 1471-2490
  databaseCode: AAJSJ
  dateStart: 20011201
  isFulltext: true
  titleUrlDefault: https://www.springernature.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: Springer Nature OA Free Journals
  customDbUrl:
  eissn: 1471-2490
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017856
  issn: 1471-2490
  databaseCode: C6C
  dateStart: 20011201
  isFulltext: true
  titleUrlDefault: http://www.springeropen.com/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LaxsxEBZNAqWX0ne3TY0Khba0S_ahZ29xSAiBpCHUYHoRklaClHZt4vUh_6U_tjPatRP3cejFC15pLe83o5mRZj4R8sZJr0Oly9wK1-TMB5ErrsqcM6sdOrTeYzXy6Zk4nrCTKZ8ONDlYC3N7_75UYm8B8yeS11aYYqYYxDtbZIfDxIvpewfiYL1jIBUXq6KYv_bbMDyJn__PWfiWGfptXzSZm6MH5P7gJ9L9HtiH5E5oH5G7p8NO-GPyE_Cls2UHAgPXSAGsdOYDtW1DL7sFbZY9tjSdAk7n15gbBK5yd00vW7qq4aa4DkuXV5gUM5uH7zBv0G9g6lLPmVuzy9J3k_OTz-8_UUtvuJ9pX_eSfvJH6GxuB4aTJ2RydPjl4DgfTlrIPXhAXV5XhQpIfuWcBfvuhItBqTJGDdGzjUWoQx3LUBesRHog5q2vQXG95l7g2eD1U7LdztrwnFDnpPBKcO10ZDI6ZXldNA2EZU0Fzykz8mEFg5n3hBomBSJKmB40A6CZBJphGRkjUuuWSIadvgAZMYNumYYx7Qpn68gC-CNSN6WUIlheFdHHRmTkLeJsUGW7KwuD7ysPYMBIfmX2FQenUkGwnpHdjZagan7z9kpSzKDqCwMeqQSnqSphsK_Xt7Enpq-1YbZMbTCXmOsqI896CVv_JYYrZVIUGfm4Ermbh__7zbz4v-Yvyb0qKYPOi3qXbIP4hFfgTnVuRLbkVI7Izvjw7PxilLRqlJYm4PNi_PUX5HYb5Q
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGkIAXxJ3AACOBAI1ouTiOg4TQuEzdpYOHVeqbsR0bDUFS2lSo_4XfwG_kHCdpKQje9hSpcRw3526f8x1CHuncFDYp4lBxXYbMWB6KTMRhxlSh0aE1BquRh8d8MGIH42y8QX72tTCYVtnrRK-oy9rgHvkOGP4cbFMSs1eTbyF2jcLT1b6FRssWh3bxHUK22cv9t0Dfx0my9-7kzSDsugqEBqx9E6ZJJCwCPWmtwJZprp0VInaugEhRucimNnWxhTA_RigcZpRJgUlNkRmOfbBTmPccOc9gAGL15-NlgIeN7nlfmCP4zgx0PwLvJpgeJxjEamvGz_cI-NsS_GYK_zib9SZv7wq53PmqdLdlrqtkw1bXyIVhdxp_nfwAHqP1vIEPCFdHgWF83wmqqpKeNjNazlv-or4TOZ0sMD8J3PVmQU8r2teRU9wLpvMpJubUE_sFdBf9DObWP1nrJcItfTr6cPD-2Quq6Ap_mra1N_6VX22jQtWhrNwgozOhy02yWdWVvU2o1jk3gmeFLhzLnRYqS6OyhNCwTGCeOCDbPRnkpAX1kD4YEly2RJNANOmJJllAXiOlliMRkNv_UE8_yU6-ZclYoSOtUscs-ER5UcZ5zq3KksgZV_KAPEE6S1QbzVTB4tvqB1gwAnDJXZGBYyvSVARka20kiLtZv91ziuzUzUyuhCMgD5e38UlMoatsPfdjMJ85K5KA3Go5bPmXGO7W5TwKyPOe5VaT__vL3Pn_Wh6Qi4OT4ZE82j8-vEsuJV4QijBKt8gmsI69B-5co-97GaLk41kL7S_Y21nc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaglSouiDeBAkZCAgRR87Adm9vyWJWFlkpQqTfLdmxUBMlqN3vof-HHMuMk2y6PA6dIie3YGY_nm3jmMyFPbOWUL1SeGmHrlDkvUsllnnJmlEVA6xxmIx8civ1jNjvhJxey-GO0-7gl2ec0IEtT0-3N69CruBR7S1hVkdK2wMAzycALuky2JVcC3K_tyWT2ebbeSagkF2OyzF9rbhikyNv_5-p8wTz9tl8azdD0Grk64Ec66QV-nVzyzQ2yczDskN8kP0HutF11MCa4BrrEUUFL1DQ1Pe2WtF71MqfxdHA6P8OYIYDQ3Rk9beiY203x_yxdLTBYpp3777Ce0G9gAmPN1q5ZZ-mz46PZp-evqKHnnNC0z4eJr_zhO5OagfnkFjmevvvyZj8dTmBIHSCjLi2LTHokxbLWgN23wgYvZR6CAq_ahMyXvgy5LzOWI20Qc8aVoNBOcSfwzPDyNtlq2sbfJdTaSjgpuLIqsCpYaXiZ1TW4a3UB7eQJeTGKQc97og0dHRQpdC80DULTUWiaJeQ1SmpdEkmy44128VUPOqdrxpTNrCkD84BTKlXnVSW84UUWXKhFQp6inDWqcrcw0Pk-IwE6jKRYeiI5gE0JTnxCdjdKggq6zcfjTNHDErDUgFQrAFNFDp19vH6MNTGsrfHtKpbBGGOuioTc6WfYekgM_6BVIkvIy3HKnTf-7y9z7_-KPyI7R2-n-uP7ww_3yZUi6oVKs3KXbMFM8g8AcXX24aBUvwCr9yQL
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+outcome+of+stenting+and+its+duration+after+pyeloplasty+in+children+with+ureteropelvic+junction+obstruction+%3A+a+systematic+review+and+meta-analysis&rft.jtitle=BMC+urology&rft.au=Wiratma%2C+Made+Kresna+Yudhistira&rft.au=Ghinorawa%2C+Tanaya&rft.au=Yuri%2C+Prahara&rft.date=2025-09-03&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2490&rft.eissn=1471-2490&rft.volume=25&rft.issue=1&rft_id=info:doi/10.1186%2Fs12894-025-01841-4&rft.externalDocID=A854238338
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2490&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2490&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2490&client=summon